, Protection personnelle antivectorielle (PPAV)
un répulsif pour vêtements, une moustiquaire, et l'utilisation de la climatisation) a été prescrite chez 84,3 % des voyageurs séniors (n=349) ,
, La prescription d'une PPAV a été observée avec la répartition suivante : 92,5 % (n=173) pour les voyageurs vers l'Afrique sub-saharienne, 95,6 % (n=65) pour les voyageurs vers l'Amérique du Sud et 92,8 % (n=64) pour les voyageurs vers l
, On n'observait pas de différence significative sur l'indication d'une prescription de PPAV selon la présence ou l'absence d'un antécédent chez le voyageur sénior (p=0,66)
, % (n=70) des voyageurs sans pathologie chronique contre 46 % (n=116) avec pathologie chronique, vol.43
UNWTO Tourism Highlights, Organisation Mondiale du Tourisme, vol.1, 2018. ,
Risk factors and pre-travel healthcare of international travellers attending a Dutch travel clinic: a crosssectional analysis, Travel Med Infect Dis. oct, vol.12, issue.5, pp.511-535, 2014. ,
The elderly, the young and the pregnant traveler --A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination, Travel Med Infect Dis. déc, vol.13, issue.6, pp.475-84, 2015. ,
A profile of travelers -an analysis from a large swiss travel clinic, J Travel Med, vol.21, issue.5, pp.324-355, 2014. ,
Demographics, health and travel characteristics of international travellers at a pre-travel clinic in Marseille, France, Travel Med Infect Dis. sept, vol.10, issue.5-6, pp.247-56, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01307761
Stürchler null. Malaria Prophylaxis in Different Age Groups, J Travel Med. 1 déc, vol.3, issue.4, pp.219-242, 1996. ,
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. 36. 15 avr, vol.8, pp.990-995, 2003. ,
Dengue severity in the elderly in Puerto Rico, Rev Panam Salud Publica. juin, vol.13, issue.6, pp.362-370, 2003. ,
Travel-Associated Illness in Older Adults (>60 y), J Travel Med. 1 mai, vol.19, issue.3, pp.169-77, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01313286
Health Risks of Travelers With Medical Conditions -A Retrospective Analysis, J Travel Med. avr, vol.19, issue.2, pp.104-114, 2012. ,
Chronic illnesses in travelers to developing countries, Travel Med Infect Dis. déc, vol.12, pp.757-63, 2014. ,
Retrospective analysis of older travellers attending a specialist travel health clinic, Trop Dis Travel Med Vaccines, vol.5, p.17, 2019. ,
Potential drug interactions in travelers with chronic illnesses: a large retrospective cohort study, Travel Med Infect Dis. oct, vol.12, issue.5, pp.499-504, 2014. ,
Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers, vol.24, pp.6808-6819, 2006. ,
Antibody response to influenza vaccination in the elderly: a quantitative review, Vaccine. 20 févr, vol.24, issue.8, pp.1159-69, 2006. ,
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review, Vaccine. 2 déc, vol.31, issue.49, pp.5798-805, 2013. ,
Travel-related morbidity in travelers with insulindependent diabetes mellitus, J Travel Med. mars, vol.6, issue.1, pp.12-17, 1999. ,
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey, J Travel Med. févr, vol.11, issue.1, pp.3-8, 2004. ,
Les décès de français lors d'un séjour à l'étranger et leurs causes, Bull Épidémiologique Hebd, pp.166-174, 2006. ,
Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter. Open Forum Infect Dis, vol.5, p.266, 2018. ,
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions, Pharmacoepidemiol Drug Saf, vol.28, issue.11, pp.1457-63, 2019. ,
, Bulletin Epidémiologique Hebdomadaire 2019 -Recommandations sanitaires pour les voyageurs, 2019.
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors, Expert Opin Drug Metab Toxicol, vol.12, issue.4, pp.423-454, 2016. ,
Malaria in the returning older traveler, Trop Dis Travel Med Vaccines, vol.2, issue.2, 2016. ,
Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults, J Travel Med. août, vol.17, issue.4, pp.250-255, 2010. ,
Adherence to chemoprophylaxis and Plasmodium falciparum anti-aircumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers, PloS One. févr, vol.8, issue.2, p.56863, 2013. ,
, Malarone (atovaquone and proguanil hydrochloride). GlaxoSmithKline, 2019.
Pancytopenia due to proguanil toxicity in a returning traveller with fever, Eur J Clin Pharmacol. août, vol.66, issue.8, pp.811-813, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00587607
New guidelines for the prevention of imported malaria in France, Med Mal Infect. 28 août, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02479509
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir, AIDS Lond Engl. 15 mai, vol.24, issue.8, pp.1223-1229, 2010. ,
A potential interaction between warfarin and atovaquone, Ann Pharmacother. janv, vol.45, issue.1, p.3, 2011. ,
Interaction entre la fluindione et le traitement par atovaquone-proguanil d'un paludisme à P. falciparum, Thérapie. oct, vol.73, issue.5, pp.445-452, 2018. ,
Interaction of thyroxine sodium with antimalarial drugs, BMJ. 31 mai, vol.314, issue.7094, p.1593, 1997. ,
Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients, Eur J Clin Pharmacol, vol.30, issue.1, pp.105-113, 1986. ,
The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man, Br J Clin Pharmacol. sept, vol.16, issue.3, pp.245-52, 1983. ,
Doxycycline carrageenate--an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate, Eur J Clin Pharmacol, vol.46, issue.2, pp.143-149, 1994. ,
The effect of rifampicin on the pharmacokinetics of doxycycline. Infection, vol.16, pp.297-305, 1988. ,
Methotrexate and doxycycline interaction: a rare cause of pancytopenia, BMJ Case Rep. 31 mai, vol.12, issue.5, p.229296, 2019. ,
Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants, J Thromb Haemost JTH. févr, vol.6, issue.2, pp.284-90, 2008. ,
Drug interactions with antimalarial medications in older travelers: a clinical guide, J Travel Med, vol.27, issue.1, 2019. ,
Effect of ampicillin on mefloquine pharmacokinetics in Thai males, Eur J Clin Pharmacol, vol.40, issue.6, pp.631-634, 1991. ,
Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers, J Clin Pharm Ther. juin, vol.30, issue.3, pp.285-90, 2005. ,
Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers, J Pharm Pharmacol, vol.52, issue.10, pp.1265-1274, 2000. ,
, Vaccination des personnes âgées. Haut conseil de la santé publique, HCSP, 2016.
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response, J Immunol. 1 mars, vol.184, issue.5, pp.2518-2545, 2010. ,
Hepatitis-B vaccination in the elderly, J Infect Dis. juin, vol.149, issue.6, p.1019, 1984. ,
Yellow fever 17D vaccine safety and immunogenicity in the elderly, Hum Vaccin, vol.1, issue.5, pp.207-221, 2005. ,
Advanced age a risk factor for illness temporally associated with yellow fever vaccination, Emerg Infect Dis. déc, vol.7, issue.6, pp.945-51, 2001. ,
The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review, Am J Trop Med Hyg. févr, vol.86, issue.2, pp.359-72, 2012. ,
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly, J Travel Med. avr, vol.13, issue.2, pp.78-83, 2006. ,
Immunogenicity of combined hepatitis A and B vaccine in elderly persons, Vaccine. 8 sept, vol.21, pp.3623-3631, 2003. ,
Immunogenicity of Twinrix in older adults: a critical analysis, Expert Rev Vaccines. févr, vol.2, issue.1, pp.9-14, 2003. ,
Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults, Vaccine. 9 févr, vol.25, issue.8, pp.1503-1511, 2007. ,
Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory, Epidemiol Mikrobiol Imunol Cas Spolecnosti Epidemiol Mikrobiol Ceske Lek Spolecnosti JE Purkyne. sept, vol.60, issue.3, pp.99-108, 2011. ,
Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance, Arch Intern Med. 23 mars, vol.158, issue.6, pp.633-641, 1998. ,
The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule--a case series of 420 travelers, J Travel Med, vol.18, issue.5, pp.327-359, 2011. ,
Effet de l'âge sur les titres d'anticorps à la suite d'un protocole de vaccination antirabique post-exposition, Pathol Biol, vol.60, issue.5, pp.322-325, 2012. ,
Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Emerg Infect Dis. août, vol.8, issue.8, pp.761-767, 2000. ,
Awareness of Meningococcal Disease among Travelers from the United Kingdom to the Meningitis Belt in Africa, Am J Trop Med Hyg. 6 août, vol.91, issue.2, pp.281-286, 2014. ,
Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial, Drugs Aging. mai, vol.30, issue.5, pp.309-328, 2013. ,
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, Vaccine, vol.31, issue.38, pp.4579-85, 2016. ,
, Enquête Vie Quotidienne et Santé -Résultats départementaux d'une enquête auprès des seniors, DREES, 2014.
Travellers' profile, travel patterns and vaccine practices--a 10-year prospective study in a Swiss Travel Clinic, J Travel Med. janv, vol.23, issue.1, 2016. ,
Séroprévalence des maladies à prévention vaccinale et de cinq autres maladies infectieuses en France. Résultats de deux enquêtes nationales, Bull Epidémiol Hebd. 10 déc, pp.526-560, 2008. ,
Hajj-associated infections, Med Mal Infect, vol.46, issue.7, pp.346-54, 2016. ,